Stay ahead in life sciences
Expert regulatory insights, compliance guidance, and industry analysis, delivered to your inbox every two weeks.
No spam, ever. Unsubscribe anytime. Read our Privacy Policy.
What you'll receive
Curated content from our team of 250+ life sciences consultants across Europe.
Regulatory intelligence
Be the first to know about regulatory shifts impacting pharma, biotech, and medical devices.
Expert analysis
Deep-dive articles from seasoned consultants with decades of hands-on GxP experience.
Compliance insights
Practical guidance on quality management, validation, and audit-readiness.
Event & webinar alerts
Early access to webinars, workshops, and industry events.
See what lands in your inbox
A sneak peek at recent editions of the QbD Group newsletter.
QbD INSIGHTS
Edition #47 · Jan 2026
Featured
EU MDR Transition: What Manufacturers Need to Know Before the 2027 Deadline
The latest guidance from the European Commission clarifies key requirements for legacy devices…
IVDR Update: Notified Body capacity report, current state and projections
Industry Trend: AI-driven pharmacovigilance, regulatory expectations in 2026
Upcoming: Free webinar on Post-Market Surveillance best practices, Feb 12
QbD INSIGHTS
Edition #46 · Dec 2025
Featured
CDx & Companion Diagnostics: Navigating the Evolving EU Regulatory Landscape
As precision medicine advances, companion diagnostic regulation is catching up. Here's your roadmap…
White Paper: Quality by Design in pharmaceutical development, 2025 edition
Compliance Alert: EMA updates GMP Annex 1, key changes for sterile manufacturing
Case Study: How we helped a biotech startup achieve EU market launch in 9 months
A taste of what's inside
Here's a selection of recent articles our subscribers received first.
Don't miss a beat
Join thousands of life sciences professionals who rely on our insights to stay compliant and competitive.